Improvement of pulmonary arterial compliance by pulmonary vasodilator in pulmonary hypertension from combined pulmonary fibrosis and emphysema.

Combined pulmonary fibrosis and emphysema Pulmonary arterial compliance Pulmonary hypertension Pulmonary vasodilator

Journal

Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463

Informations de publication

Date de publication:
2019
Historique:
received: 28 08 2019
revised: 25 09 2019
accepted: 26 09 2019
entrez: 1 11 2019
pubmed: 2 11 2019
medline: 2 11 2019
Statut: epublish

Résumé

Combined pulmonary fibrosis and emphysema (CPFE) is a common but under-recognized syndrome characterized with distinct profiles of both pulmonary fibrosis and emphysema. Pulmonary hypertension (PH) is particularly prone to develop as a common complication, leading to exercise limitation and worse prognosis of CPFE. Although the therapy of patients with PH from CPFE cannot be endorsed, an individual treatment may be considerable when accompanying severe PH. We report a case of a 71-year-old male with PH from CPFE, who improved pulmonary arterial compliance (PAC) and exercise capacity in response to pulmonary vasodilator.

Identifiants

pubmed: 31667076
doi: 10.1016/j.rmcr.2019.100940
pii: S2213-0071(19)30267-9
pii: 100940
pmc: PMC6812224
doi:

Types de publication

Case Reports

Langues

eng

Pagination

100940

Informations de copyright

© 2019 The Authors.

Déclaration de conflit d'intérêts

The authors have no conflict of interest to declare. Morio Y. is an equally contributed author in the present case report.

Références

PLoS One. 2015 Dec 02;10(12):e0141911
pubmed: 26630396
Chest. 2012 Jan;141(1):222-231
pubmed: 22215830
Eur Respir J. 2005 Oct;26(4):586-93
pubmed: 16204587
Chest. 2013 Jun;143(6):1699-1708
pubmed: 23732584
Nat Med. 2005 Feb;11(2):214-22
pubmed: 15665834
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16
pubmed: 24355635
Eur Respir J. 2010 Jan;35(1):105-11
pubmed: 19643948
Eur Respir J. 2019 Jan 24;53(1):null
pubmed: 30545980
Respirology. 2015 Jul;20(5):805-12
pubmed: 25828844
Eur Respir Rev. 2013 Jun 1;22(128):153-7
pubmed: 23728869
Int J Cardiol. 2017 Mar 1;230:53-58
pubmed: 28038821
Cardiovasc Ther. 2014 Oct;32(5):202-8
pubmed: 24909193
Chest. 2009 Jul;136(1):10-15
pubmed: 19225068
J Mol Med (Berl). 2013 Mar;91(3):297-309
pubmed: 23334338
Chest. 1974 Jan;65(1):29-35
pubmed: 4809331
Pulm Med. 2012;2012:867870
pubmed: 22448331

Auteurs

Kei Kusaka (K)

Center for Pulmonary Circulation and Hemoptysis, Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-shi, Tokyo, 204-8585, Japan.

Yoshiteru Morio (Y)

Center for Pulmonary Circulation and Hemoptysis, Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-shi, Tokyo, 204-8585, Japan.

Yuya Kimura (Y)

Center for Pulmonary Circulation and Hemoptysis, Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-shi, Tokyo, 204-8585, Japan.

Keita Takeda (K)

Center for Pulmonary Circulation and Hemoptysis, Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-shi, Tokyo, 204-8585, Japan.

Masahiro Kawashima (M)

Center for Pulmonary Circulation and Hemoptysis, Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-shi, Tokyo, 204-8585, Japan.

Kimihiko Masuda (K)

Center for Pulmonary Circulation and Hemoptysis, Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-shi, Tokyo, 204-8585, Japan.

Hirotoshi Matsui (H)

Center for Pulmonary Diseases, Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-shi, Tokyo, 204-8585, Japan.

Classifications MeSH